The Japan CDISC Coordinating Committee (J3C) held its second annual CDISC Japan Interchange in Tokyo, July 11-13. The group, which is part of the Austin, Texas, USA-based Clinical Data Interchange Standards Consortium, is a non-profit organization, whose mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of health care. The CDISC's main project, the described data standard, bears the same name.
The J3C reports that all indicators show that "the interest and activities associated with CDISC standards have increased dramatically since last year's J3C event."
80% more attendees than in 2005
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze